Hey all - long time reader of all things PTX here. I've got a question regarding the response rates/benefit rates presented at the latest briefing - hoping someone could shed some light on.
The stats around the Overall Response Rates & Clinical Benefit Rates are composed of patients that have reached the end of cycle 4 of treatment (a cycle being 14 days). Most of the more recent patients unfortunately haven't reaching this time point. My question is around why the ORR/CBR is measured with the cohort of patients that have reached the end of C4? I'm assuming this has to do with the study design - but clarification would be helpful! Is this benchmark typical for a study like ours?
From the swimmer plot, a number of patients would have gone through about 2 cycles of treatment. If the benchmark is arbitrary, and hypothetically we were to include these patients in calculating efficacy - does this mean PTX100 may not be as effective?
- Forums
- ASX - By Stock
- PTX
- Ann: PTX-100 Spotlight Presentation
Ann: PTX-100 Spotlight Presentation, page-18
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
-0.002(3.70%) |
Mkt cap ! $31.40M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.9¢ | $31.53K | 794.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 456872 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 66952 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 456872 | 0.039 |
12 | 1469182 | 0.038 |
2 | 103515 | 0.037 |
5 | 429500 | 0.036 |
5 | 313576 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 66952 | 1 |
0.042 | 380000 | 3 |
0.043 | 300000 | 2 |
0.044 | 210000 | 2 |
0.045 | 407000 | 3 |
Last trade - 15.43pm 24/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |